Results 11 to 20 of about 42,137 (194)

Attenuation of niacin-induced prostaglandin D2 generation by omega-3 fatty acids in THP-1 macrophages and Langerhans dendritic cells

open access: yesJournal of Inflammation Research, 2012
Justin VanHorn1, Jeffrey D Altenburg1, Kevin A Harvey1, Zhidong Xu1, Richard J Kovacs2, Rafat A Siddiqui1,31Cellular Biochemistry Laboratory, Methodist Research Institute, Indianapolis, 2Krannert Institute of Cardiology, Indianapolis, 3Department of ...
VanHorn J   +5 more
doaj   +1 more source

Niacin and Stroke: The Role of Supplementation and Emerging Concepts in Clinical Practice, a Narrative Review

open access: yesCurrent Issues in Molecular Biology
Niacin therapy has been a mainstay in traditional secondary prevention of stroke. Supplemental use of niacin has been used to improve lipid panel markers, including lowering low-density lipoproteins and triglycerides, and raising high-density ...
Alan D. Kaye   +7 more
doaj   +2 more sources

Nicotinamide riboside and pterostilbene reduces markers of hepatic inflammation in NAFLD: A double‐blind, placebo‐controlled clinical trial

open access: yesHepatology, EarlyView., 2022
NRPT 1X reduces ALT and ceramide 14:0 in 65% of subjects as compared to only 28% in the placebo group. Abstract Background and Aims The prevalence of NAFLD is increasing globally and on a path to becoming the most frequent cause of chronic liver disease. Strategies for the prevention and treatment of NAFLD are urgently needed.
Ryan W. Dellinger   +7 more
wiley   +1 more source

maf167/Niacin-Metabolites-and-vascular-inflammation-and-residual-cardiovascular-disease-risk: version 1

open access: yes, 2023
Custom code repository for the peer-reviewed article "Terminal metabolites of niacin, a component of cereal fortification, are associated with vascular inflammation and residual cardiovascular disease ...
maf167
core   +1 more source

maf167/Niacin-Metabolites-and-vascular-inflammation-and-residual-cardiovascular-disease-risk: version 2

open access: yes, 2023
Custom code repository for the peer-reviewed article "Terminal metabolites of niacin, a component of cereal fortification, are associated with vascular inflammation and residual cardiovascular disease ...
maf167
core   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

maf167/Niacin-Metabolites-and-vascular-inflammation-and-residual-cardiovascular-disease-risk: version 3

open access: yes, 2023
Custom code repository for the peer-reviewed article "Terminal metabolites of niacin, a component of cereal fortification, are associated with vascular inflammation and residual cardiovascular disease ...
maf167
core   +1 more source

maf167/Niacin-Metabolites-and-vascular-inflammation-and-residual-cardiovascular-disease-risk: version 4

open access: yes, 2023
<p>Custom code repository for the peer-reviewed article "Terminal metabolites of niacin, a component of cereal fortification, are associated with vascular inflammation and residual cardiovascular disease risk"</p ...
maf167
core   +1 more source

EFFECT OF LOW-DOSE NIACIN ON DYSLIPIDEMIA, SERUM PHOSPHORUS LEVELS AND ADVERSE EFFECTS IN PATIENTS WITH CHRONIC KIDNEY DISEASE

open access: yesKidney Research and Clinical Practice, 2012
Niacin supplementation improves dyslipidemia and lowers serum phosphorus levels in chronic kidney disease (CKD) patients. However, its adverse effects, including hot flusing, hinder the administration of niacin.
Won Suk An, Hyo Jin Kang, Ki Hyun Kim
doaj   +1 more source

Scientific Opinion on Dietary Reference Values for niacin [PDF]

open access: yesEFSA Journal, 2014
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies (NDA) derived Dietary Reference Values (DRVs) for niacin. Niacin is a generic term for nicotinic acid and nicotinamide. Niacin can be synthesised in
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
doaj   +1 more source

Home - About - Disclaimer - Privacy